Table 1.
Variables | Name of scale | #Items | Reliability | HIV-1 RNA viral load (log10 copies/mL)
|
CD4 lymphocytes (cells/ mm3)
|
|||||
---|---|---|---|---|---|---|---|---|---|---|
Int | Slopepre | Slopepost | pomni | Int | Slope | pomni | ||||
Demographics | ||||||||||
Age in years | 1 | – | −0.09 | 0.07 | −0.07 | 0.85 | −24.02 | −0.29 | 0.45 | |
ART naive (%) | 1 | – | 0.46* | −0.25 | 0.03 | 0.02 | −6.19 | 21.96* | 0.04 | |
Employed (%) | 1 | – | −0.22 | 0.07 | −0.32 | 0.05 | 61.41 | 30.37* | 0.003† | |
Female (%) | 1 | – | −0.10 | 0.16 | −0.09 | 0.83 | −12.79 | 6.57 | 0.74 | |
Heterosexual (%) | 1 | – | −0.04 | 0.16 | −0.15 | 0.90 | −17.86 | −14.49 | 0.10 | |
HS graduate (%) | 1 | – | −0.15 | −0.39 | 0.48 | 0.16 | 56.74 | 4.27 | 0.16 | |
Income <$553/ month (%) | 1 | – | 0.07 | 0.14 | −0.08 | 0.42 | −17.68 | −24.04* | 0.003 | |
Partnered (%) | 1 | – | −0.02 | 0.00 | 0.05 | 0.97 | 0.78 | −1.99 | 0.96 | |
Race | 3 | 0.60 | 0.58 | |||||||
Black vs. White | – | 0.06 | 0.15 | −0.07 | −61.86* | 5.22 | ||||
Latino vs. White | – | 0.11 | −0.25 | 0.27 | 11.78 | 5.70 | ||||
Other vs. White | – | −0.27 | 0.61 | −0.76 | −59.25 | −10.55 | ||||
Years since diagnosis | 1 | – | −0.05 | 0.31* | −0.34* | 0.08 | −11.03 | −3.64 | 0.32 | |
Psychosocial | ||||||||||
Alcohol abuse | AUDIT | 10 | 0.88 | 0.17 | −0.11 | 0.06 | 0.23 | −23.28 | 5.87 | 0.04 |
ART knowledge | Investigator’s | 13 | 0.63 | −0.17 | 0.09 | −0.11 | 0.37 | 33.95** | 1.16 | 0.11 |
ART self-efficacy | Investigator’s | 14 | 0.96 | −0.26** | 0.20 | −0.26 | 0.03 | 37.17** | −5.48 | 0.14 |
Drug abuse | DAST | 28 | 0.89 | 0.13 | −0.11 | 0.14 | 0.55 | 7.39 | −4.56 | 0.35 |
General social support | MOS-SS | 20 | 0.47 | −0.09 | 0.07 | −0.13 | 0.52 | −20.59 | 6.03 | 0.16 |
Network orientation | NOS | 20 | 0.77 | 0.03 | −0.03 | 0.12 | 0.13 | 13.44 | −8.21* | 0.03 |
Perceived stress | PSS | 14 | 0.86 | 0.19* | −0.23 | 0.24 | 0.27 | 3.02 | −7.59* | 0.03 |
Physical health status | MOS-HIV | 20 | 0.80 | −0.25** | 0.21 | −0.19 | 0.15 | 32.27** | 6.86 | 0.02 |
Social desirability | MCSDS | 10 | 0.57 | −0.01 | 0.13 | −0.09 | 0.32 | −12.87 | 2.49 | 0.62 |
Spirituality | SBI-15 | 15 | 0.97 | −0.03 | −0.12 | 0.22 | 0.19 | −23.73 | 1.04 | 0.30 |
Mental health | ||||||||||
Depression | CES-D | 20 | 0.92 | 0.14 | −0.09 | 0.06 | 0.52 | 4.94 | −7.23* | 0.04 |
Mental health status | MOS-HIV | 24 | 0.94 | −0.21* | 0.14 | −0.12 | 0.22 | 12.03 | 7.86* | 0.03 |
State anxiety | STAI | 10 | 0.89 | 0.13 | −0.10 | 0.14 | 0.49 | −2.26 | −4.44 | 0.33 |
Trait anxiety | STAI | 10 | 0.89 | 0.14 | −0.12 | 0.14 | 0.54 | 7.26 | −6.61 | 0.09 |
p<0.05.
p<0.01.
Statistically significant after Benjamini-Hochberg alpha correction (bolded). All continuous measures were standardized (i.e., mean=0, SD=1).
Int, intercept; pomni, omnibus p value; ART, antiretroviral therapy; AUDIT, Alcohol Use Disorders Test (Saunders, Aasland, Babor, de la Fuente, & Grant, 1993); DAST, Drug Base Screening Test (Skinner, 1982); MOS-SS, Medical Outcome Study Social Support Survey (Sherbourne & Stewart, 1991); NOS, Network Orientation Scale (Vaux, 1985); PSS, Perceived Stress Scale (Cohen, Kamarck, &Mermelstein, 1983); STAI, State-Trait Anxiety Inventory (Spielberger, 1983); MOS-HIV, Medical Outcome Study HIV Health Survey (Hays, Sherbourne, & Mazel, 1995); MCSDS, Marlow-Crowne Social Desirability Scale (Crowne & Marlowe, 1980); SBI-15, Systems of Belief Inventory (Holland et al., 1998); CESD, Centers for Epidemiologic Studies Depression Scale (Radloff, 1977).